Filing Details
- Accession Number:
- 0001737287-24-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-10 16:53:55
- Reporting Period:
- 2024-12-09
- Accepted Time:
- 2024-12-10 16:53:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1737287 | Allogene Therapeutics Inc. | ALLO | Biological Products, (No Disgnostic Substances) (2836) | 823562771 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754424 | M. Deborah Messemer | 210 East Grand Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-09 | 9,136 | $2.18 | 157,629 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.16 to $2.21, inclusive. The reporting person undertakes toprovide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate pricewithin the range set forth above.
Billionaire Hedge Funds
